Methods for treating cancer using 3-[1,3dioxo-4-benzamidoisoindolin-2-yl]-2,6-dioxo-5-hydroxypiperidine
申请人:Celgene Corporation
公开号:US07834033B2
公开(公告)日:2010-11-16
Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group, which may be further substituted in the 5-position with alkyl or halogeno, and in the 4-position with alkyl or a nitrogen-containing group are inhibitors of, and thus useful in the treatment of disease states mediated by, TNFα. A typical embodiment is 2-(2,6-dioxo-3-hydroxy-5-fluoro-piperidin-5-yl)4-aminoisoindolin-1-one.
在2-位置上取代了2,6-二氧杂环己酮-3-羟基哌啶-5-基团的异吲哚啉-1-酮和异吲哚啉-1,3-二酮,该基团在5-位置上可能进一步取代为烷基或卤素,在4-位置上取代为烷基或含氮基团,可用于抑制TNFα,因此对治疗由此介导的疾病状态有用。一个典型的实施例是2-(2,6-二氧-3-羟基-5-氟哌啶-5-基)4-氨基异吲哚啉-1-酮。